Srikara Parenterals Private Limited, a active private limited company, was established on 25 April 2005 in Unguturu Mandal, Andhra Pradesh, India. Engaging in medical consumables & supplies within the healthcare sector, it holds CIN: U24244AP2005PTC045974. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹7.98 Cr.
It upholds a active non-compliant status. Its leadership includes Sri Devi Gorla (Director), Naga Manikyala Rao Gorla (Managing Director), Prem Raj Rayepudi (Director). Past directors included Naga Manikyala Rao Gorla, Srinivas Babji Vaitla, Prem Raj Rayepudi. It holds ₹9.28 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4-113-1, Kanaka Durga Temple Street, Atkuru, Unguturu Mandal, Andhra Pradesh, 521286.
U24244AP2005PTC045974
045974
25 April 2005
₹10.00 Cr
₹7.98 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Srikara Parenterals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sri Devi Gorla | Director | 25 Apr 2005 | Current |
| Naga Manikyala Rao Gorla | Managing Director | 25 Apr 2005 | Current |
| Prem Raj Rayepudi | Director | 01 Sep 2011 | Current |
| Gorla Venkata Syam Murali Krishna | Director | 01 Sep 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Dec 2008 | Past |
| Pramod Abcsdd | Whole-Time Director | 10 Jul 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
| Pramod Abcsdd | Managing Director | 10 Jul 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Srikara Parenterals Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 30.02% decrease. The company also saw a slight decrease in profitability, with a 5.96% decrease in profit. The company's net worth Soared by an impressive increase of 12.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2015, Srikara Parenterals had a promoter holding of 24.13% and a public holding of 75.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹92,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jan 2005 | State Bank Of India | ₹9.28 Cr | Open |
Explore comprehensive loan charge details -
Srikara Parenterals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Srikara Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srikara Parenterals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Srikara Parenterals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Srikara Parenterals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.
Progress on A charge with State Bank Of India of Rs. 9.28 Cr registered on 09 Jan 2005 with Charge ID 90343578 was modified on 02 Sep 2013. was documented.
The activity Prem Raj Rayepudi was appointed as a Director was appointed as a Director on 01 Sep 2011 & has been associated with this company since 14 years 3 months . was completed.
Gorla Venkata Syam Murali Krishna was appointed as a Director was appointed as a Director on 01 Sep 2011 & has been associated with this company since 14 years 3 months . was recorded as a recent event.
Sri Devi Gorla was appointed as a Director was appointed as a Director on 25 Apr 2005 & has been associated with this company since 20 years 8 months . was recorded as a recent event.
The CIN of Srikara Parenterals Private Limited is U24244AP2005PTC045974.
Srikara Parenterals Private Limited is headquartered at 4-113-1, Kanaka Durga Temple Street, Atkuru, Unguturu Mandal, Andhra Pradesh, 521286.
Srikara Parenterals Private Limited was incorporated on 25 April 2005.
The current directors of Srikara Parenterals Private Limited are
The primary industry of Srikara Parenterals Private Limited is Healthcare.
Srikara Parenterals Private Limited is unlisted.
The authorized capital of Srikara Parenterals Private Limited is ₹10.00 Cr, and the paid-up capital is ₹7.98 Cr.
The compliance status of Srikara Parenterals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX